Saint Agnes Hospital is proud to announce that the Commission on Cancer (CoC) of the American College of Surgeons has awarded the Cancer Institute at Saint Agnes Three-Year Accreditation with Commendation, which is the highest level of accreditation for a cancer program.
A facility receives a Three-Year Accreditation with Commendation following the on-site evaluation by a physician surveyor during which the facility demonstrates it has exceeded the standard level of compliance with all of the CoC standards that represent the full scope of the cancer program including cancer committee leadership, cancer date management, clinical services, research, community outreach, and quality improvement.
“The Cancer Institute at Saint Agnes strives to provide the highest level of cancer care to our patients,” said Dr. Carole Miller, director of the Cancer Institute. “Receiving the highest level of accreditation from the CoC reinforces our team approach of using the most advanced techniques and clinical expertise along with compassionate care that allow cancer patients need to take control of their illness.”
The American Cancer Society estimates that 1.5 million cases of cancer will be diagnosed in 2011. Currently only approximately 25 percent of all hospitals in the United States and Puerto Rico are accredited by the CoC and only 14 percent of that 25 percent have attained accreditation level of 3-Yr w/Commendation. This 25 percent of all hospitals diagnose and/or treat 71 percent of newly diagnosed patients each year.
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving survival rate and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. The Accreditation Program, a component of the CoC, set quality-of-car standards for cancer programs and reviews the programs to ensure they conform to those standards. To maintain accreditation, facilities with CoC-accredited cancer programs must undergo an on-site evaluation every three years.